Related links
Trial | NCT02152228 - Clinical Drug Experience Knowledgebase
Brief Summary. This is an observational, international, open label, pilot study to evaluate the safety, tolerability and efficacy of an oral PTH (1-34) ...
Learn more
Dear Healthcare Provider Letter for Natpara (parathyroid hormone)
September 24, 2019 Subject: IMPORTANT INFORMATION REGARDING NEW PROGRAM FOR OBTAINING AND USING NATPARA (parathyroid hormone) for injection Dear Healthcare ...
Learn more
Label: NATPARA (PARATHYROID HORMONE) - DailyMed
Confirm serum calcium is above 7.5 mg/dL before starting NATPARA. The goal of NATPARA treatment is to achieve serum calcium within the lower half of the normal ...
Learn more